The amount of BCR-ABL fusion transcripts detected by the real-time quantitative polymerase chain reaction method in patients with Philadelphia chromosome positive chronic: Myeloid leukemia correlates with the disease stage

Annals of Hematology

Volumn 79, Issue 8, 2000, Pages 424-431

  Elmaagacli, A H ^a   Beelen, D W ^a   Opalka, B ^a   Seeber, S ^a   Schaefer, U W ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

BCR ABL fusion transcripts; Chronic myeloid leukemia; Philadelphia chromosome; Real time quantitative polymerase chain reaction

Indexed keywords

ALPHA INTERFERON; BCR ABL PROTEIN; BUSULFAN; COMPLEMENTARY DNA; CYCLOPHOSPHAMIDE; DNA POLYMERASE; FLUDARABINE; IMMUNOSUPPRESSIVE AGENT; MESSENGER RNA; REAGENT; RNA DIRECTED DNA POLYMERASE; THIOTEPA; THYMOCYTE ANTIBODY;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER IMMUNOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CELL STRAIN K 562; CHROMOSOME ANALYSIS; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS;

BONE MARROW TRANSPLANTATION; FUSION PROTEINS, BCR-ABL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOID, CHRONIC-PHASE; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; NEOPLASM RECURRENCE, LOCAL; RECURRENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY;

EID: 0033884287     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770000169     Document Type: Article

References (27)

1. Beelen DW, Quabeck K, Kaiser B, Wiefelspütz J, Scheulen ME, Graeven U, Grosse-Wilde H, Sayer HG, Schaefer UW (1990) Six weeks of continuous intravenous cyclosporine and short course methotrexate as propyhlaxis for acute graft-versus-host disease after allogeneic hone marrow transplantation. Transplantation 50:421-427
2. Beelen DW, Ottinger HD, Elmaagacli AH, Scheulen B, Basu O, Kremens B, Havers W, Grosse-Wild H, Schaefer UW (1997) Transplantation of filgrastim-mobilized peripheral blood stem cells from HLA-identical sibling or alternative family donors in patients with hematologic malignancies: a prospective comparison on clinical outcome, immune reconstitution, and hematopoietic chimerism. Blood 90:4725-4732
3. Chomczynski P, Sacchi N (1987) Single step method of RNA isolation by acid guanidium thiocyanate phenol chloroform extraction. Anal Biochem 162:156-159
4. Cross NCP, Feng L, Chase A, Bungey J, Hughes TP, Goldman JM (1993) Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation. Blood 82:1929-1936
5. Desjardin LE, Chen Y, Perkins MD, Teixeira L, Cave MD, Eisenach KD (1998) Comparison of the ABI 7700 System (TaqMan) and competitive PCR for quantification of IS6110 DNA in sputum during treatment of tuberculosis. J Clin Microbiol 36:1964-1968
6. Dveksler GS, Basile AA, Dieffenbach CW (1992) Analysis of gene expression: use of oligonucleotide primers for glyceraldehyde-3-phosphate dehydrogenase. PCR methods and applications (vol 1). Cold Spring Harbor Laboratory Press, pp 283-284
7. Elmaagacli AH, Beelen DW, Schaefer UW (1997) A retrospective single centre study of the outcome of five different therapy approaches in 48 patients with relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation. Bone Marrow Transplant 20:1045-1055
8. Elmaagacli AH, Beelen DW, Opalka B, Seeber S, Schaefer UW (1999) The risk of residual molecular and cytogenetic disease in patients with Philadelphia-chromosome positive first chronic phase chronic myelogenous leukemia is reduced after transplantation of allogeneic peripheral blood stem cell compared with bone marrow. Blood 15:384-389
9. Emig M, Saussele S, Wittor H, Weiser A, Reiter A, Willer A, Berger U, Hehlmann R, Cross N, Hochhaus A (1999) Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR. Leukemia 13:1825-32
10. Faderl S, Talpaz M, Hagop M, Kantarjian M, Estrov Z (1999) Should polymerase chain reaction analysis to detect minimal residual disease in patients with chronic myelogenous leukemia be used in clinical decision making? Blood 93:2755-2759
11. Förster VTH (1948) Zwsichenmolekulare Energiewanderung und Fluoreszenz. Ann Physics (Leipzig) 2:55-75
12. Gluckberg H, Storb R, Fefer A, Buckner CD, Neimann PE, Clift RA, Lerner KG, Thomas ED (1974) Clinical manifestations of graft-versus-host-disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 18:295-304
13. Goldman JM, Gale RP, Horowitz MM, Biggs JC, Chamblin RE, Gluckman E, Hoffmann RG, Jacobsen SJ, Marmont AM, McGlave PB, Messner HA, Rimm AA, Rozman C, Speck B, Tura S, Weiner RS, Bortin MM (1988) Bone marrow transplantation for chronic myelogenous leukemia in chronic phase: increased risk of relapse associated with T-cell depletion. Ann Intern Med 108:806-814
14. Goldman JM, Kaeda JS, Cross NCP (1999) Clinical decision making in chronic myeloid leukemia based on polymerase chain reaction analysis of minimal residual disease. Blood 94:1484-1486
15. Holland PM, Abramson RD, Watson R, Gelfand DH (1991) Detection of specific polymerase chain reaction product utilizing the 5′-3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci USA 88:7276-7280
16. Kolb H, Mittermüller J, Clemm C, Holler E, Lederose G, Brehm G, Heim M, Wilmanns W (1990) Donor leucocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 76:2462-2465
17. Kwok S, Higuchi R (1989) Avoiding false positives with PCR. Nature 339:237-238
18. Lee LG, Conell CR, Bloch W (1993) Allelic discrimination by nick-translation PCR with fluorgenic probes. Nucleic Acids Res 21:3761-3766
19. Lin F, van Rhee F, Goldman JM, Cross NCP (1996) Kinetics of increasing BCR-ABL transcript numbers in chronic myeloid leukemia patients who relapse after bone marrow transplantation. Blood 87:4473-4478
20. Marcucci G, Livak KJ, Bi W, Strout MP, Bloomfield CD, Caligiuri MA (1998) Detection of minimal residual disease in patients with AML1/ETO-associated acute myeloid leukemia using a novel quantitative reverse transcription polymerase chain reaction assay. Leukemia 12:1482-1489
21. Mensink E, van de Locht A, Schattenberg A, Linders E, Schaap N, Geurts can Kessel A, De Witte T (1998) Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukemia patients using real-time quantitative PCR. Br J Haematol 102:768-774
22. Preudhomme C, Revillion F, Merlat A, Hornez L, Roumier C, Duflos-Grardel N, Jouet JP, Cosson A, Peyrat JP, Fenaux P. (1999) Detection of bcr-abl transcripts in chronic myeloid leukemia using a "real time" quantitative RT-PCR assay. Leukemia 13:957-964
23. Radich JP, Gehly G, Gooley T, Bryant E, Clift RA, Collins S, Edmands S, Kirk J, Lee A, Kessler P, Schoch G, Buckner CD, Sullivan KM, Appelbaum FR, and ED Thomas (1995) Polymerase chain reaction detection of the BCR/ABL fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: results and implications in 346 patients. Blood 85:2632-2638
24. Roth MS, Antin JH, Bingham EL and Ginsburg D (1989) Detection of Philadelphia chromosome-positive cells by the polymerase chain reaction following bone marrow transplant for chronic myelogenous leukemia. Blood 74:882-885
25. Smetsers TFCM, Stevens EHP, van de Locht LTF, Mensink EJBM (1998) Freezing of PCR master mixture retains full amplification activity and facilitates PCR standardisation for molecular diagnostics and real-time quantitative PCR (letter). Leukemia 12:1324
26. Thomas ED, Storb R, Clift RA, Fefer A, Johnson FL, Neimann PE, Lerner K, Glucksberg H, Buckner CD (1975) Bone marrow transplantation. New Engl J Med 292:895-902
27. Thomas ED, Clift RA, Fefer A, Appelbaum FR, Beatty P, Bensinger WI, Buckner CD, Cheever MA, Deeg HJ, Doney K, Flournoy N, Greenberg P, Hansen JA, Martin P, McGuffin R, Ramberg R, Sanders JE, Singer J, Stewart P, Storb R, Sullivan K, Weiden PL, Witherspoon R (1986) Marrow transplantation for the treatment of chronic myelogenous leukemia. Ann Intern Med 104:155-161